Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

544.41
-1.7800-0.33%
Post-market: 544.410.00000.00%19:50 EST
Volume:348.44K
Turnover:189.60M
Market Cap:12.36B
PE:-41.76
High:555.50
Open:546.00
Low:535.33
Close:546.19
52wk High:605.00
52wk Low:265.00
Shares:22.71M
Float Shares:11.00M
Volume Ratio:1.42
T/O Rate:3.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.0355
EPS(LYR):-21.9007
ROE:-41.22%
ROA:-15.78%
PB:19.76
PE(LYR):-24.86

Loading ...

Madrigal Pharmaceuticals Inc : H.c. Wainwright Assumes Coverage With Buy Rating; Target Price $500

THOMSON REUTERS
·
Sep 04

U.S. RESEARCH ROUNDUP-CBRE Group, Horizon Bancorp, Ulta Beauty

Reuters
·
Aug 26

Madrigal Pharmaceuticals Inc : TD Cowen Raises Target Price to $554 From $390

THOMSON REUTERS
·
Aug 26

William John Sibold, President and CEO of Madrigal Pharmaceuticals Inc., Reports Disposal of Common Shares

Reuters
·
Aug 22

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 22

Baker Bros. Advisors LP Reports Acquisition of Common Shares in Madrigal Pharmaceuticals Inc

Reuters
·
Aug 21

Madrigal Pharmaceuticals Is Maintained at Market Outperform by JMP Securities

Dow Jones
·
Aug 20

Madrigal Pharmaceuticals Wins EU Approval for Rezdiffra

MT Newswires Live
·
Aug 20

Madrigal Pharmaceuticals Inc - Planning for Its First European Launch in Germany in Q4 of 2025

THOMSON REUTERS
·
Aug 20

Madrigal Receives European Commission Approval for Rezdiffra™ (Resmetirom) for Treatment of Mash With Moderate to Advanced Liver Fibrosis

THOMSON REUTERS
·
Aug 20

Madrigal Receives European Commission Approval for Rezdiffra™ (resmetirom) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis

GlobeNewswire
·
Aug 20

Kelley Shannon T, General Counsel, Reports Disposal of Common Shares of Madrigal Pharmaceuticals Inc

Reuters
·
Aug 19

BUZZ-U.S. STOCKS ON THE MOVE-Soligenix, BioXcel, GoodRx

Reuters
·
Aug 18

BUZZ-Madrigal Pharma down; Novo's Wegovy gets FDA approval for liver disease

Reuters
·
Aug 18

S&P 500 Futures Decline In Premarket Trading; Dayforce, JBS Lead

Dow Jones
·
Aug 18

Director Kenneth Bate Reports Disposal of Common Shares of Madrigal Pharmaceuticals Inc

Reuters
·
Aug 16

Director Paul A. Friedman Reports Disposal of Common Shares of Madrigal Pharmaceuticals Inc

Reuters
·
Aug 14

Director Rebecca Taub Reports Disposal of Common Shares of Madrigal Pharmaceuticals Inc

Reuters
·
Aug 14

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference

GlobeNewswire
·
Aug 11

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 08